Homepage Featured News

July 20, 2021

Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic

Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021

November 18, 2021

Guardant Health Reports Third Quarter 2021 Financial Results

Achieved record revenue of $94.8 million, Growth of 35% and 58% year over year in clinical and biopharma volumes, respectively